Sold as Osteoscan, Technetium Tc 99m Diphosphonate-Tin, Cintichem Technetium 99m Hedspa, Mpi Stannous Diphosphonate. Every FDA application for this active ingredient.
As of Nov 15, 2026, FDA lists 4 applications for Technetium Tc-99m Etidronate Kit (sold as Osteoscan, Technetium Tc 99m Diphosphonate-Tin, Cintichem Technetium 99m Hedspa and others), first approved Sep 28, 1973, with 1 new use approved and 0 published complete response letters.
| Sep 28, 1973 | OsteoscanNDA 17454 · New molecular entity | Mallinckrodt | 15 | Discontinued |
| Aug 5, 1976 | Technetium Tc 99m Diphosphonate-TinNDA 17562 · New formulation or manufacturer | Ge Healthcare | 1 | Discontinued |
| Nov 18, 1976 | Cintichem Technetium 99m HedspaNDA 17653 · New formulation or manufacturer | Ge Healthcare | 4 | Discontinued |
| Apr 1, 1977 | Mpi Stannous DiphosphonateNDA 17667 · New formulation or manufacturer | Ge Healthcare | 2 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA